Pfizer Newsroom

Jefferies Adjusts Price Target on Pfizer to $35 From $34, Keeps Buy Rating

MT Newswires59minutes ago

J.P. Morgan Sticks to Its Hold Rating for Pfizer (PFE)

TipRanksJul 30 09:56 ET

Buy Rating Affirmed: Sangamo's Hemophilia A Gene Therapy Poised for Success With Pfizer Partnership

TipRanksJul 24 10:27 ET

Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com

Barron'sJul 22 08:58 ET

Pfizer's Mixed Outlook: Hold Rating Amidst Vyndaqel's Growth and Falling Demand for Comirnaty and Paxlovid

TipRanksJul 17 11:47 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Corcept Therapeutics (CORT) and Pfizer (PFE)

TipRanksJul 17 11:42 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: KalVista Pharmaceuticals (KALV), Roche Holding AG (OtherRHHVF) and Pfizer (PFE)

TipRanksJul 16 00:25 ET

Hold Rating on Pfizer: Caution Advised Amid Uncertainties Surrounding Danuglipron

TipRanksJul 12 04:57 ET

Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF) and Pfizer (PFE)

TipRanksJul 12 04:53 ET

Jefferies Sticks to Their Buy Rating for Pfizer (PFE)

TipRanksJul 11 15:57 ET

Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Pfizer (PFE)

TipRanksJul 10 20:23 ET

Pfizer Analyst Ratings

BenzingaJul 10 10:08 ET

Pfizer (PFE) Gets a Buy From Cantor Fitzgerald

TipRanksJul 1 20:27 ET

Pfizer Analyst Ratings

BenzingaJul 1 11:21 ET

Pfizer Analyst Ratings

BenzingaJun 26 12:11 ET

Pfizer Analyst Ratings

BenzingaJun 17 13:34 ET

Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target

BenzingaJun 17 13:33 ET

Balanced Outlook Amidst Strategic Shifts: Pfizer's Hold Rating Explained

TipRanksMay 30 23:00 ET

Pfizer's Acoramidis Shows Promising Survival Trends: A Buy Rating Endorsement

TipRanksMay 30 22:26 ET

Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE)

TipRanksMay 28 01:16 ET